Briacell Therapeutics
BCTX
13 hedge funds and large institutions have $69.2K invested in Briacell Therapeutics in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.15% less ownership
Funds ownership: 0.66% → 0.51% (-0.15%)
49% less capital invested
Capital invested by funds: $137K → $69.2K (-$67.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$42.2K |
| 2 |
Morgan Stanley
New York
|
+$35.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.06K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$3.17K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
+$981 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$122K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
-$880 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$94 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FHA
1
Flagship Harbor Advisors
Boston,
Massachusetts
| $28.4K | +$42.2K | +4,000 | New |
|
|
2
Morgan Stanley
New York
| $24.9K | +$35.7K | +3,387 | +2,971% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $8.57K | +$3.17K | +300 | +33% |
|
|
4
UBS Group
Zurich,
Switzerland
| $4.54K | +$6.06K | +574 | +897% |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
AF
6
Allworth Financial
Folsom,
California
| $711 | +$981 | +93 | +1,329% |
|
7
Group One Trading
Chicago,
Illinois
| $498 | – | – | – |
|
|
SSA
8
SSA Swiss Advisors
Zurich,
| $264 | +$390 | +37 | New |
|
|
TWC
9
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $135 | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $64 | +$95 | +9 | New |
|
|
HWA
11
HHM Wealth Advisors
Chattanooga,
Tennessee
| $43 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $7 | – | – | – |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$122K | -11,055 | Closed |
|
|
SS
14
SBI Securities
Tokyo,
Japan
| – | -$880 | -80 | Closed |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | -$94 | -72 | Closed |
|
BCTX Hedge Fund Activity: Q4 2025 in Review
13 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Briacell Therapeutics (BCTX) for Q4 2025, worth a combined $69.2K — down 49% from $137K a quarter earlier.
Fund positioning in BCTX was balanced in Q4 2025: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Flagship Harbor Advisors, opening a new position worth an estimated $42.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $122K sold.
- 13 institutional investors held Briacell Therapeutics (BCTX) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $69.2K of Briacell Therapeutics stock for Q4 2025, down 49% quarter-over-quarter.
- 3 funds opened new Briacell Therapeutics positions in Q4 2025 and 3 closed out, a net change of 0 holders.
- The largest Briacell Therapeutics buyer in Q4 2025 was Flagship Harbor Advisors, an estimated $42.2K added.
- The largest Briacell Therapeutics seller in Q4 2025 was Citadel Advisors, an estimated $122K sold.
Based on aggregated 13F filings for Q4 2025.